HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with ...
Thought LeadersSarah Smith and Tim SimpsonSenior Marketing Manager and General ManagerHologic In celebration of International Women's Day 2024, we're honored to host Tim Simpson and Sarah Smith from ...
StockStory.org on MSN
Hologic (NASDAQ:HOLX) misses Q4 CY2025 revenue estimates
Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2025 as sales rose 2.5% year on year to $1.05 billion. Its non-GAAP ...
Hologic HOLX operates across four segments, but investor attention last year remained particularly heightened on the Breast Health business. From expected gantry slowdowns impacting sales to improved ...
Zacks Investment Research on MSN
HOLX vs. SYK: Which medical device leader is a solid bet now?
The global medical device industry is characterized by rapid technological advances, innovations and scientific discoveries.
Company Kicks Off October by Ringing Nasdaq Opening Bell, Releasing Educational Resources for Women MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s ...
Hologic's women's health business benefited from the pandemic but is now facing headwinds that will end in 2024. The company has a strong balance sheet, solid track record, and reasonable valuation, ...
As Hologic gears up to cease operations at its Danbury, Connecticut facility in December, the Marlborough-based medical device manufacturer plans tol incrementally lay off 86 employees by the end of ...
BTIG analyst Ryan Zimmerman notes that the U.S. Preventive Services Task Force released a draft recommendation statement on screening for cervical cancer, recommending testing every three years for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results